126 related articles for article (PubMed ID: 27425245)
1. The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs.
Bäumer W; Rossbach K; Schmidt BH
Vet Dermatol; 2017 Feb; 28(1):46-e11. PubMed ID: 27425245
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.
Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S
Mol Vis; 2011; 17():3208-23. PubMed ID: 22194647
[TBL] [Abstract][Full Text] [Related]
3. In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease.
Shafiee A; Bucolo C; Budzynski E; Ward KW; López FJ
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1422-30. PubMed ID: 20881303
[TBL] [Abstract][Full Text] [Related]
4. Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.
Baiula M; Bedini A; Baldi J; Cavet ME; Govoni P; Spampinato S
Drug Des Devel Ther; 2014; 8():745-57. PubMed ID: 24959069
[TBL] [Abstract][Full Text] [Related]
5. Mapracorat, a novel non-steroidal selective glucocorticoid receptor agonist for the treatment of allergic conjunctivitis.
Baiula M; Spampinato S
Inflamm Allergy Drug Targets; 2014; 13(5):289-98. PubMed ID: 25373600
[TBL] [Abstract][Full Text] [Related]
6. Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys.
Proksch JW; Lowe ER; Ward KW
Drug Metab Dispos; 2011 Jul; 39(7):1181-7. PubMed ID: 21441467
[TBL] [Abstract][Full Text] [Related]
7. Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells.
Spinelli SL; Xi X; McMillan DH; Woeller CF; Richardson ME; Cavet ME; Zhang JZ; Feldon SE; Phipps RP
Exp Eye Res; 2014 Oct; 127():290-8. PubMed ID: 25245083
[TBL] [Abstract][Full Text] [Related]
8. Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells.
Cavet ME; Volhejn S; Harrington KL; Zhang JZ
Mol Vis; 2013; 19():1515-25. PubMed ID: 23878502
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.
Schäcke H; Zollner TM; Döcke WD; Rehwinkel H; Jaroch S; Skuballa W; Neuhaus R; May E; Zügel U; Asadullah K
Br J Pharmacol; 2009 Oct; 158(4):1088-103. PubMed ID: 19422381
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of mapracorat, a novel selective glucocorticoid receptor agonist, is partially mediated by MAP kinase phosphatase-1 (MKP-1).
Vollmer TR; Stockhausen A; Zhang JZ
J Biol Chem; 2012 Oct; 287(42):35212-35221. PubMed ID: 22898817
[TBL] [Abstract][Full Text] [Related]
11. Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells.
Cavet ME; Harrington KL; Ward KW; Zhang JZ
Mol Vis; 2010 Sep; 16():1791-800. PubMed ID: 20824100
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus.
Gorouhi F; Solhpour A; Beitollahi JM; Afshar S; Davari P; Hashemi P; Nassiri Kashani M; Firooz A
J Am Acad Dermatol; 2007 Nov; 57(5):806-13. PubMed ID: 17658663
[TBL] [Abstract][Full Text] [Related]
13. Multiple-center study of reduced-concentration triamcinolone topical solution for the treatment of dogs with known or suspected allergic pruritus.
Deboer DJ; Schafer JH; Salsbury CS; Blum JR; Beale KM; Vitale CB; Muse R; Moriello KA; Garfield RA; Keefe TJ; McArthur TR
Am J Vet Res; 2002 Mar; 63(3):408-13. PubMed ID: 11911576
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs.
Wigger-Alberti W; Williams R; von Mackensen YL; Hoffman-Wecker M; Grossmann U; Staedtler G; Nkulikiyinka R; Shakery K
Skin Pharmacol Physiol; 2017; 30(2):102-114. PubMed ID: 28407625
[TBL] [Abstract][Full Text] [Related]
15. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
Olivry T; DeBoer DJ; Favrot C; Jackson HA; Mueller RS; Nuttall T; Prélaud P;
Vet Dermatol; 2010 Jun; 21(3):233-48. PubMed ID: 20456716
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of treatment with triamcinolone acetonide in calcinosis cutis following extravasation of calcium gluconate: a preliminary study.
Ahn SK; Kim KT; Lee SH; Hwang SM; Choi EH; Choi S
Pediatr Dermatol; 1997; 14(2):103-9. PubMed ID: 9144694
[TBL] [Abstract][Full Text] [Related]
17. The ocular effects of intravitreal triamcinolone acetonide in dogs.
Molleda JM; Tardón RH; Gallardo JM; Martín-Suárez EM
Vet J; 2008 Jun; 176(3):326-32. PubMed ID: 17466546
[TBL] [Abstract][Full Text] [Related]
18. Topical 'dual-soft' glucocorticoid receptor agonist for dermatology.
Dack KN; Johnson PS; Henriksson K; Eirefelt S; Carnerup MA; Stahlhut M; Ollerstam AK
Bioorg Med Chem Lett; 2020 Sep; 30(17):127402. PubMed ID: 32738970
[TBL] [Abstract][Full Text] [Related]
19. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA).
Olivry T; DeBoer DJ; Favrot C; Jackson HA; Mueller RS; Nuttall T; Prélaud P;
BMC Vet Res; 2015 Aug; 11():210. PubMed ID: 26276051
[TBL] [Abstract][Full Text] [Related]
20. Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs.
Cerrato S; Brazis P; Della Valle MF; Miolo A; Petrosino S; Di Marzo V; Puigdemont A
Vet J; 2012 Mar; 191(3):377-82. PubMed ID: 21601500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
